halofuginone has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, S; Masamune, A; Matsumoto, R; Taguchi, K; Tanaka, Y; Yamamoto, M | 1 |
| Carlson, M; Elahi-Gedwillo, KY; Provenzano, PP; Zettervall, J | 1 |
| Genin, O; Honig, H; Kawada, N; Nagler, A; Pines, M; Spector, I | 1 |
| Genin, O; Lavy, A; Nagler, A; Pines, M; Spector, I; Zilberstein, Y | 1 |
4 other study(ies) available for halofuginone and Pancreatic Neoplasms
| Article | Year |
|---|---|
Nuclear Factor Erythroid 2-Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression.
Topics: Aldehyde Dehydrogenase; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NF-E2-Related Factor 2; Pancreatic Neoplasms; Piperidines; Quinazolinones | 2021 |
Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.
Topics: Animals; Biophysical Phenomena; Carcinoma, Pancreatic Ductal; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Humans; Macrophages; Mice; Pancreatic Neoplasms; Piperidines; Quinazolinones; Random Allocation; Stromal Cells; Tumor Microenvironment | 2019 |
Inhibition of pancreatic stellate cell activation by halofuginone prevents pancreatic xenograft tumor development.
Topics: Animals; Cell Line, Tumor; Extracellular Matrix; Fibrosis; Humans; Male; Mice; Neoplasm Transplantation; Pancreas; Pancreatic Neoplasms; Pancreatic Stellate Cells; Piperidines; Quinazolinones; Transplantation, Heterologous | 2010 |
Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Ceruletide; Collagen; Extracellular Matrix; Fibrosis; Humans; Male; Mice; Mice, Transgenic; Myofibroblasts; Neoplasm Invasiveness; Pancreatic Neoplasms; Piperidines; Quinazolinones; Stromal Cells | 2012 |